✦ LIBER ✦

Concerns about data reporting and interpretation in “Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial”

✍ Scribed by David M. Marks; Jonathan S. Abramowitz; Glen I. Spielmans

Book ID: 113751029
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 84 KB
Volume: 46
Category: Article
ISSN: 0022-3956
DOI: 10.1016/j.jpsychires.2012.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of the novel t

Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

✍ Pierre Tran; Phil Skolnick; Pal Czobor; N.Y. Huang; Mark Bradshaw; Anthony McKin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Efficacy of bupropion and the selective

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: A meta-analysis of individual patient data from 10 double-blind, randomized clinical trials

✍ George I. Papakostas; Madhukar H. Trivedi; Jonathan E. Alpert; Cheryl A. Seifert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Efficacy and safety of duloxetine for tr

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

✍ I. Jon Russell; Philip J. Mease; Timothy R. Smith; Daniel K. Kajdasz; Madelaine 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 608 KB

A double-blind, placebo-controlled treat

A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: The relevance of the placebo effect and psychological symptoms

✍ Renerio Fraguas; Renata Martinho da Silva Telles; Tânia Correa Toledo Ferraz Alv 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 226 KB

A double-blind, multicenter trial compar

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

✍ Lesley M. Arnold; Yili Lu; Leslie J. Crofford; Madelaine Wohlreich; Michael J. D 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, double‐blind, placebo‐controlled trial co

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures

✍ Jonathan J. Halford; Elinor Ben-Menachem; Patrick Kwan; Seth Ness; Jennifer Schm 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 459 KB